These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33600940)

  • 1. Cullin-RING Ligases as Promising Targets for Gastric Carcinoma Treatment.
    Song Q; Feng S; Peng W; Li A; Ma T; Yu B; Liu HM
    Pharmacol Res; 2021 Aug; 170():105493. PubMed ID: 33600940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cullin-RING Ligases as attractive anti-cancer targets.
    Zhao Y; Sun Y
    Curr Pharm Des; 2013; 19(18):3215-25. PubMed ID: 23151137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
    Zhao Y; Morgan MA; Sun Y
    Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds.
    Wu K; DeVita RJ; Pan ZQ
    J Biol Chem; 2024 Mar; 300(3):105752. PubMed ID: 38354780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction.
    Sun Y
    Adv Exp Med Biol; 2020; 1217():1-8. PubMed ID: 31898218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.
    Lan H; Tang Z; Jin H; Sun Y
    Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.
    Nguyen HC; Wang W; Xiong Y
    Subcell Biochem; 2017; 83():323-347. PubMed ID: 28271482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].
    Yu Q; Xiong X; Sun Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):1-19. PubMed ID: 32621419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cullin-RING E3 ubiquitin-ligases by neddylation and dimerization.
    Merlet J; Burger J; Gomes JE; Pintard L
    Cell Mol Life Sci; 2009 Jun; 66(11-12):1924-38. PubMed ID: 19194658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destabilization of CDC6 upon DNA damage is dependent on neddylation but independent of Cullin E3 ligases.
    Tan CY; Hagen T
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1489-98. PubMed ID: 23597704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of small molecule inhibitors of neddylation catalyzing enzymes for anticancer therapy.
    Qin X; Han X; Sun Y
    Biomed Pharmacother; 2024 Oct; 179():117356. PubMed ID: 39214012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?
    Yu Q; Sun Y
    Drug Des Devel Ther; 2021; 15():1-8. PubMed ID: 33442232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Destiny for Degradation: Interplay between Cullin-RING E3 Ligases and Autophagy.
    Lu G; Wang L; Zhou J; Liu W; Shen HM
    Trends Cell Biol; 2021 Jun; 31(6):432-444. PubMed ID: 33573849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the Effects of Neddylation on Cullin-RING Ligase-Dependent Protein Ubiquitination.
    Wang K; Liu X
    Curr Protoc; 2022 Mar; 2(3):e401. PubMed ID: 35316580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein neddylation and its role in health and diseases.
    Zhang S; Yu Q; Li Z; Zhao Y; Sun Y
    Signal Transduct Target Ther; 2024 Apr; 9(1):85. PubMed ID: 38575611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of E3 ubiquitin ligases in gastric cancer.
    Hou YC; Deng JY
    World J Gastroenterol; 2015 Jan; 21(3):786-93. PubMed ID: 25624711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells.
    Luo Z; Pan Y; Jeong LS; Liu J; Jia L
    Autophagy; 2012 Nov; 8(11):1677-9. PubMed ID: 22874562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for Cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics.
    Shafique S; Ali W; Kanwal S; Rashid S
    Int J Biol Macromol; 2018 Jan; 106():532-543. PubMed ID: 28802844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.